OncoSec Medical Inc (ONCS)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

24 N. MAIN STREET PENNINGTON, NJ 08534

OncoSec Medical Incorporated designs, develops, and commercializes novel cancer therapeutic products in the United States. Its products combine proprietary electroporation delivery technology with a chemotherapeutic or novel DNA-based immunotherapeutics, known as OMS ElectroOncology. The companys immunotherapy program uses the OncoSec Medical System to deliver engineered DNA plasmid constructs that encode a specific cytokine. It has three Phase II clinical trials underway with its OMS ElectroImmunotherapy product.

Data based on most recent fiscal year report
Market Cap84.592 Million Shares Outstanding42.94 Million Avg Volume1.392 Million
1-Yr BETA vs S&P TR1.012 Current Ratio3.68 Quick Ratio3.68
View SEC Filings from ONCS instead.
Q3 2019 All Institutions Hedge Funds 1
To trade ONCS now:
Filers who had this stock in their top 10: 0 0 (0.0%)
13F Filers holding this stock: 23 2 (0.21%)
Aggregate 13F shares on 09/30/2019: 767.497 Thousand 279.679 Thousand
Aggregate 13F shares on 06/30/2019: 620.07 Thousand 240.314 Thousand
Percent change: 23.78% 16.38%
Funds creating new positions: 5 1
Funds Adding to an existing position: 2
Funds closing out their position: 3 2
Funds reducing their position: 4
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ONCS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

3.2 Thousand total shares from 2 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

O'CONNOR DANIEL J. CEO AND PRESIDENT

  • Officer
  • Director
68,715 2019-10-31 5

BONSTEIN SARA CFO/COO

  • Officer
42,740 2019-10-16 5

WARD ROBERT CHAIRMAN AND CEO

170,953 2019-09-26 1

ALPHA HOLDINGS, INC.

  • Director
  • 10% Owner
1,611,000 2019-07-17 5

JENKINS ANNALISA

  • Director
33,471 2019-06-13 0

MAIDA ANTHONY E III

  • Director
0 2019-05-31 0

DALESANDRO MARGARET

  • Director
0 2019-04-24 2

MAYES, GREGORY T.

  • Director
0 2019-02-27 1

DEMESA JAMES M

  • Director
0 2019-01-02 2

DHILLON AVTAR S

  • Director
0 2019-01-02 1

DHILLON PUNIT

  • Director
0 2019-01-02 1

KIM JOON

  • Director
0 2019-01-02 2

SLANSKY RICHARD B CHIEF FINANCIAL OFFICER

  • Officer
270,016 2018-06-15 0

MOHAN-PETERSON SHEELA CHIEF LEGAL&COMPLIANCE OFFICER

  • Officer
9,520 2017-07-31 0

GARGOSKY SHARRON E CHIEF CLINICAL & REG. OFFICER

  • Officer
0 2017-03-29 0

PIERCE ROBERT HAMILTON CHIEF SCIENTIFIC OFFICER

  • Officer
0 2016-03-04 0

LE MAI HOPE CHIEF MEDICAL OFFICER

  • Officer
0 2015-08-20 0

VALLEJO VERONICA CHIEF FINANCIAL OFFICER

  • Officer
0 2015-03-03 0

CROSS MICHAEL CHIEF OPERATING OFFICER

  • Officer
1,214,000 2011-03-10 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

O'CONNOR DANIEL J. - Director - Officer CEO AND PRESIDENT

2019-10-31 S 2,128 $2.16 d 68,715 68,715.00 direct

BONSTEIN SARA - Officer CFO/COO

2019-10-16 S 1,111 $2.01 d 42,740 42,740.00 direct

**EXPERIMENTAL** Current Active Short Positions

Get more info on our International short position coverage here

Holder Issuer Net Short Position Position Date Origin

Short Position History

Holder Net Short Position Position Date Origin
Squarepoint Ops LLC OncoSec Medical Inc 0.64% 2019-05-31 UK
Squarepoint Ops LLC OncoSec Medical Inc 0.54% 2019-05-30 UK
Squarepoint Ops LLC OncoSec Medical Inc 1.98% 2019-08-15 UK
Click here to report any possible errors with this stock listing.

Elevate your investments